Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
12/12/25 16:15 | 12/10/25 | RDNT | Health | Health | Medical Laboratories | Stolper Mark | CA | O | EVP,CFO | 2 | M.d | 2,803 | 39.64 | 0 | 71 | 214 | 104 | D | ||||||||||||||
12/12/25 16:15 | 12/10/25 | RDNT | Health | Health | Medical Laboratories | Katz David Jeffrey | CA | O | EVP,GC | 1 | M.d | 100 | 29.44 | 0 | 3 | 5 | 72 | D | ||||||||||||||
12/9/25 16:15 | 12/5/25 | RDNT | Health | Health | Medical Laboratories | Forthuber Stephen M | CA | O | P,COO-Ea | 2 | S.d | -3,769 | 44.76 | 0 | -84 | 574 | D | |||||||||||||||
11/21/25 16:15 | 11/19/25 | RDNT | Health | Health | Medical Laboratories | Berger Howard G | CA | DO | P,CEO | 1 | M.d | 2,422 | 18.64 | 0 | 130 | 55 | 368 | D | ||||||||||||||
11/19/25 18:10 | 11/17/25 | RDNT | Health | Health | Medical Laboratories | Patel Mital | CA | O | EVP of F | 1 | S.m | -3,902 | 78.05 | 0 | -50 | 180 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |